Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $33
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $32 to $33.
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $32 to $33.